Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Duramed Cenestin DTC Ads Aim To Chill Premarin With New, "Cool" Message

Executive Summary

Duramed's Cenestin (synthetic conjugated estrogens, A) direct-to-consumer print ad campaign emphasizes the plant-source of the product as an alternative to Wyeth-Ayerst's equine-derived Premarin.

You may also be interested in...



Duramed Cenestin

The product is designated synthetic conjugated estrogens, A to identify it as the first synthetic conjugated estrogen drug product (1"The Pink Sheet" Sept. 20, p. 23)

Duramed Cenestin

The product is designated synthetic conjugated estrogens, A to identify it as the first synthetic conjugated estrogen drug product (1"The Pink Sheet" Sept. 20, p. 23)

Cardinal To Promote Duramed's Cenestin Via CSO Subsidiary

Cardinal will be competing with Premarin manufacturer Wyeth-Ayerst through its promotional agreement for Duramed's conjugated estrogens product Cenestin.

Related Content

UsernamePublicRestriction

Register

LL111799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel